Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Barr

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Journal of Immunology|August 7, 2012
T(FH) memory: more or less T(FH)?Tom Barr, David Gray
European Journal of Immunology|November 15, 2007
Innate responses of B cellsDavid Gray, Mohini Gray, Tom Barr
Current Opinion in Molecular Therapeutics|March 1, 2005
Adjuvanticity of anti-cD40 in vaccine developmentJennifer Cairing, Tom Barr, Andrew W Heath
Vaccine|July 11, 2006
Antibodies against cell surface antigens as very potent immunological adjuvantsTom Barr, Jennifer Carlring, Caterina Hatzifoti, et al.
Plos One|April 13, 2012
Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cellsStefano Caserta, Norman Nausch, Amy Sawtell, et al.
Immunology|November 26, 2009
Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearanceSuzanne Talbot, Sabine Tötemeyer, Masahiro Yamamoto, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Journal of Immunology|August 7, 2012
T(FH) memory: more or less T(FH)?Tom Barr, David Gray
European Journal of Immunology|November 15, 2007
Innate responses of B cellsDavid Gray, Mohini Gray, Tom Barr
Current Opinion in Molecular Therapeutics|March 1, 2005
Adjuvanticity of anti-cD40 in vaccine developmentJennifer Cairing, Tom Barr, Andrew W Heath
Vaccine|July 11, 2006
Antibodies against cell surface antigens as very potent immunological adjuvantsTom Barr, Jennifer Carlring, Caterina Hatzifoti, et al.
Plos One|April 13, 2012
Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cellsStefano Caserta, Norman Nausch, Amy Sawtell, et al.
Immunology|November 26, 2009
Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearanceSuzanne Talbot, Sabine Tötemeyer, Masahiro Yamamoto, et al.
Pageof 1